St. George's University School of Medicine, True Blue, Grenada.
Keck School of Medicine of USC, Los Angeles, USA.
Sleep Breath. 2022 Sep;26(3):1277-1280. doi: 10.1007/s11325-021-02452-7. Epub 2021 Sep 10.
Congenital Central Hypoventilation Syndrome (CCHS) requires lifelong ventilatory support during sleep. Subjects with CCHS are vulnerable to sleep disturbances associated with treatments, monitoring alarms, and care they receive. We hypothesized that sleep would be disrupted in patients with CCHS due to ventilatory support and other treatments at night.
An anonymous survey of patients with CCHS, age up to 17 years was conducted through REDCAP. Subjects were recruited in person, by flyer, email, and social media. Data collected included demographics, PHOX2B genotype, ventilatory support, treatments, nursing, and sleep parameters.
We received 23 responses (35% female, 8.1 years ± 5.6). PHOX2B genotypes were 20/24 PARM (2), 20/25 PARM (4), 20/26 PARM (2), 20/27 PARM (9), ≥ 20/28 PARM (2), and NPARM (2). Two subjects did not indicate the PHOX2B genotype. 13/23 were ventilated by PPV via tracheostomy, 7 by NIPPV, 2 by diaphragm pacing, and 1 did not indicate. Additional treatments received at night included suctioning (9), aerosol (1), G-tube feeding (2), and none (11). Only 9 received nursing at night. 13 used pulse oximetry for monitoring, and 9 used both pulse oximetry and end tidal CO monitor. 17/23 rarely woke up due to ventilator or monitor alarms. 11/23 usually or sometimes woke up at least once a night; only 2/11 woke up due to alarms. 5/17 who rarely woke up to the alarms had night nursing.
Most subjects with CCHS did not awaken to ventilator or monitoring alarms and a majority of these patients did not have nighttime nursing. (Mathur et al. in Sleep 43(Supplement_1):A333, 2020).
先天性中枢性肺泡通气不足综合征(CCHS)在睡眠期间需要终生通气支持。CCHS 患者易受与治疗、监测警报和护理相关的睡眠障碍影响。我们假设由于夜间通气支持和其他治疗,CCHS 患者的睡眠会受到干扰。
通过 REDCAP 对年龄在 17 岁以下的 CCHS 患者进行匿名调查。通过传单、电子邮件和社交媒体招募患者。收集的数据包括人口统计学资料、PHOX2B 基因型、通气支持、治疗、护理和睡眠参数。
我们收到了 23 份回复(35%为女性,年龄为 8.1±5.6 岁)。PHOX2B 基因型为 20/24 PARM(2)、20/25 PARM(4)、20/26 PARM(2)、20/27 PARM(9)、≥20/28 PARM(2)和 NPARM(2)。有 2 位患者未表明 PHOX2B 基因型。23 例患者中,13 例经气管切开行机械通气(PPV),7 例经无创通气(NIPPV),2 例经膈肌起搏,1 例未表明。夜间还接受了其他治疗,包括吸痰(9)、雾化(1)、胃管喂养(2)和无(11)。仅 9 例夜间接受护理。13 例使用脉搏血氧仪进行监测,9 例同时使用脉搏血氧仪和呼气末二氧化碳监测仪。17/23 例患者很少因呼吸机或监测警报而醒来。11/23 例患者通常或有时每晚至少醒来一次,仅有 2/11 例因警报而醒来。在很少因警报醒来的 5/17 例患者中,有夜间护理。
大多数 CCHS 患者不会因呼吸机或监测警报而醒来,且大多数患者夜间没有护理。(Mathur 等人,在《睡眠》43(增刊 1):A333,2020 年)。